Partners in improving local health NHS Confidential / Protect / Unclassified - Slide 1 Medicines Optimisation So – are we there yet? Janette Stephenson Head of Medicines Optimisation NECS

Partners in improving local health Medicines Optimisation Principles NHS Confidential / Protect / Unclassified - Slide 2

Partners in improving local health Medicines Optimisation – The Strategic Context PPRS - NHS England response to PPRS agreement “Ensuring medicines use is patient centred and focused on value, quality and outcomes will help seize the opportunity of the 2014 PPRS agreement” Kings Fund Poly Pharmacy and Medicines Optimisation NICE short clinical guideline published 2015 NHS Confidential / Protect / Unclassified - Slide 3

Partners in improving local health What messages do they have? NICE GUIDANCE (NG5) Between 2003 and 2013 the average number of prescriptions for any one person per year in England rose from 13 to 19 Better use of data Patient centered care ( including shared decision making ) Transfer of care Medication safety Kings Fund In problematic polypharmacy, there can be increased risk of drug interactions and ADRs, impaired adherence and QoL for patients NHS Confidential / Protect / Unclassified - Slide 4

Partners in improving local health So what about The North East? NHS Confidential / Protect / Unclassified - Slide 5

Partners in improving local health Use of tools proven to improve medication safety NHS Confidential / Protect / Unclassified - Slide 6

Partners in improving local health Medication safety - Medicines Reconciliation NHS Confidential / Protect / Unclassified - Slide 7

Partners in improving local health Medication safety - A culture of reporting NHS Confidential / Protect / Unclassified - Slide 8

Partners in improving local health Use of services known to increase adherence to medicines NHS Confidential / Protect / Unclassified - Slide 9

Partners in improving local health Use of services known to increase adherence to medicines NHS Confidential / Protect / Unclassified - Slide 10

Partners in improving local health Use of services known to support patients in their medicines taking NHS Confidential / Protect / Unclassified - Slide 11

Partners in improving local health Use of services known to support patients in their medicines taking NHS Confidential / Protect / Unclassified - Slide 12

Partners in improving local health Use of services known to support patients in their medicines taking NHS Confidential / Protect / Unclassified - Slide 13

Partners in improving local health Prescribing of antibacterials NHS Confidential / Protect / Unclassified - Slide 14

Partners in improving local health Use of antibiotics known to increase the risk of C. Diff by CCG NHS Confidential / Protect / Unclassified - Slide 15

Partners in improving local health Adoption of NICE approved medicines NHS Confidential / Protect / Unclassified - Slide 16

Partners in improving local health Use of diabetes drugs NHS Confidential / Protect / Unclassified - Slide 17

Partners in improving local health Respiratory Drugs NHS Confidential / Protect / Unclassified - Slide 18

Partners in improving local health So what about The North East? NHS Confidential / Protect / Unclassified - Slide 19 Lots of good work going on ! Repeat Dispensing Emergency Supply Schemes AHSN MO Workstream Care Homes Referral to pharmacy Inhaler technique training Antibiotic campaign Practice pharmacists NTAG PINCER SIRMS

Partners in improving local health So are we there yet? Not quite!. Great examples of good practice Parts of area doing a lot with MO priorities eg repeat dispensing, medication review, improving prescribing quality Well established networks: LPNs, AHSN, NESPM Need to join up system Lots more opportunities to use pharmacists. Many of the tools are already in the box but were not using them consistently! NHS Confidential / Protect / Unclassified - Slide 20

Partners in improving local health And finally.. Working together is key to all of this. Eventually if we don’t put all this in place we wont have the assurance that medicines are being used well, so investment in new medicines that will help patients will be much riskier Or if we do get it right, we can be assured that patients will use medicines well and therefore the price tag is much less important NHS Confidential / Protect / Unclassified - Slide 21